Binbin Cheng - Concepedia

Author

Binbin Cheng

Southern Medical University ORCID

Also Known As

Binbin Cheng

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Southern Medical University Hubei Polytechnic University Lishui City People's Hospital Wenzhou Medical University Zunyi Medical University

About

Binbin Cheng is an author at Southern Medical University specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	340
2	Biomolecular Engineering	3	3	149
3	Natural Sciences	2	2	46
4	Engineering	1	1	102
5	Biochemistry	1	1	25

Binbin Cheng

Publications

658

Citations

H-Index

Page 1

	Year	Citations
Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1 Binbin Cheng, Yichang Ren, Hao Cao, European Journal of Medicinal Chemistry Medicinal ChemistryEngineeringDual InhibitorsMedicineDrug Discovery	2020	102
Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities Yichang Ren, Yuxi Wang, Gang Li, Journal of Medicinal Chemistry	2021	100
HDAC-targeting epigenetic modulators for cancer immunotherapy Binbin Cheng, Wei Pan, Yao Xiao, European Journal of Medicinal Chemistry Hdac-targeting Epigenetic ModulatorsMedicineEpigenetic ChangeImmunologyTumor Immunity	2024	79
Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer Agents Binbin Cheng, Yichang Ren, Xiaoge Niu, Journal of Medicinal Chemistry	2020	78
Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment Xin Deng, Ruiyao Mai, Chen‐Yu Zhang, European Journal of Medicinal Chemistry Cell-based Drug DeliveryNanomedicineProgrammable DeliveryDrug TargetingPolymer-drug Conjugate	2020	66
Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment Binbin Cheng, Wei Wang, Xiaoge Niu, Journal of Medicinal Chemistry	2020	47
Discovery of novel CA-4 analogs as dual inhibitors of tubulin polymerization and PD-1/PD-L1 interaction for cancer treatment Xuchao Yang, Binbin Cheng, Yao Xiao, European Journal of Medicinal Chemistry Novel Ca-4 AnalogsPolymer-drug ConjugateMedicineDrug DiscoveryTubulin Polymerization	2020	33
Biophysical basis underlying dynamic Lck activation visualized by ZapLck FRET biosensor Rongxue Wan, Jenny Wu, Mingxing Ouyang, Science Advances	2019	31
Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities Yichang Ren, Yong Ruan, Binbin Cheng, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryPolymer-drug ConjugateMedicineNatural Sciences	2021	25
Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment Hao Cao, Binbin Cheng, Ting Liu, Biochemical Pharmacology Medicinal ChemistryNovel Resorcinol BiphenylBenign Toxicity ProfilesMedicineNatural Sciences	2021	21

Page 1